Providing evidence-based information in a practical, easy-to-read format for practicing clinicians, investigators, industry scientists, and other entities involved in the field of neuroscience
Current Issue • July–September 2024
Letter to the Editor: Activation of the Serotonergic Neurotransmission is a Double-edged Sword in the Treatment of Burning Mouth Syndrome

By |September 1, 2024|Comments Off on Letter to the Editor: Activation of the Serotonergic Neurotransmission is a Double-edged Sword in the Treatment of Burning Mouth Syndrome

Innov Clin Neurosci. 2024;21(7–9):8–9. Dear Editor: In the treatment of chronic pain of unknown cause, contradictions can arise; a drug for the treatment of a disease might be a cause of the disease. Burning mouth [...]

Study of Clinical Characteristics of Intellectual Disability in Morocco

By |September 1, 2024|Comments Off on Study of Clinical Characteristics of Intellectual Disability in Morocco

by Houda Bekkari , PhD; Dr. Yousra Benmakhlouf, PhD; Prof. Naima Ghailani Nourouti, PhD; Prof. Amina Barakat, PhD; and Prof. Mohcine Bennani Mechita, PhD All authors are with Intelligent Automation and BioMed Genomics Laboratory, Faculty [...]

Neuropsychological Functioning Among Patients with OCD in Asian Countries: A Systematic Review

By |September 1, 2024|Comments Off on Neuropsychological Functioning Among Patients with OCD in Asian Countries: A Systematic Review

by Uzma Ilyas, PhD scholar; Sabeela Saher, MS scholar; Ayesha Ahmad Khan, MS scholar; Anam Shahid, PhD Scholar; and Zarmeen Tariq, MS Ms. Ilyas is Senior Lecturer, Department of Psychology, Forman Christian College University in [...]

Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review

By |September 1, 2024|Comments Off on Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review

by Waguih William IsHak, MD; Ashley Meyer, BS; Luiza Freire, MD; Jayant Totlani, DO; Nathalie Murphy, MD; Sabrina Renteria, MD; Mohamed Salem, BS; Tiffany Chang, MS; Rasha Abdelsalam MD; Rida Khan, MD; Thomas Chandy, MS, [...]

Risk Management: Fires, Floods, Hurricanes, Oh My! The Importance of Disaster Planning

By |September 1, 2024|Comments Off on Risk Management: Fires, Floods, Hurricanes, Oh My! The Importance of Disaster Planning

by Akemini “Kem” Isang, RN, JD Ms. Isang is a Senior Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: The author is an [...]

Letter to the Editor: Whether Telerehabilitation is Actually Beneficial in Iatrogenic Facial Palsy Needs to be Confirmed by Prospective, Multicenter, Controlled Studies

By |December 1, 2023|Comments Off on Letter to the Editor: Whether Telerehabilitation is Actually Beneficial in Iatrogenic Facial Palsy Needs to be Confirmed by Prospective, Multicenter, Controlled Studies

Funding/financial disclosures. The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2023;20(10–12):8. Dear Editor: We read with [...]

Left Ventricular Noncompaction Cardiomyopathy Diagnosis in a Patient Presenting with Epileptic Seizure: A “Double-edged Sword”

By |December 1, 2023|Comments Off on Left Ventricular Noncompaction Cardiomyopathy Diagnosis in a Patient Presenting with Epileptic Seizure: A “Double-edged Sword”

by Eirini Beneki, MD, MSc, PhD; Kyriakos Dimitriadis, MD, PhD; Konstantinos Tsatiris, MD, MSc; Konstantina Aggeli, MD, PhD; and Konstantinos Tsioufis, MD, PhD Drs. Beneki, Dimitriadis, Aggeli, and Tsioufis are with First Cardiology Department, School [...]

Past Articles
Letter to the Editor: Responding to commentary: addressing points raised in the correspondence about “ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain”

By |June 1, 2024|

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. The authors have no conflicts of interest relevant to the contents of this letter. No funding was received for the preparation of this letter. Dear Editor: It was with [...]

Letter to the Editor: Responding to correspondence on “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

By |June 1, 2024|

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Citrome is a consultant for AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Eisai, Enteris BioPharma, HLS Therapeutics, Idorsia, INmune [...]

Letter to the Editor: Response to “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

By |June 1, 2024|

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Zaragoza Domingo is co-author and intellectual property owner of the EPICOG-SCH battery. No funding was received for the preparation of this letter. Dear Editor: As co-author of the [...]